27 Jan 2021 --- Lonza has reported a “strong” performance for its 2020 financial year. Notably, the Capsules & Health Ingredients segment benefited from increased demand for nutritional supplements caused by the COVID-19 pandemic.“The full-year results reflect our commitment and focus to maintaining operations throughout the pandemic, while making an active and decisive contribution to controlling it,” says Pierre-Alain Ruffieux, CEO, Lonza Group.
